Latest News

Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Scientists discover link between common medications and serious falls in older men

  • Sleepy fruitflies get mellow

  • Research grasps how brain plans gripping motion

  • How to digitally stoke that old-time auction fever

  • Autism costs estimated to reach nearly 0 billion, potentially trillion, by 2025

  • Coffee consumption habits impact the risk of mild cognitive impairment

  • Very early birth linked to introversion, neuroticism, risk aversion in adulthood

  • Where memory is encoded and retrieved: New findings in a long-standing debate

  • Neurology researchers evaluate evidence base for tests for clinical cognitive assessment

  • Majority rule: Why conformity can actually be a good thing

  •